Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Rowe

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Annals of Internal Medicine|July 2, 2016
Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for PainPhillip O Coffin, Emily Behar, Christopher Rowe, et al.
Journal of General Internal Medicine|November 6, 2016
Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for PainEmily Behar, Christopher Rowe, Glenn-Milo Santos, et al.
The International Journal on Drug Policy|January 22, 2018
Using medical examiner case narratives to improve opioid overdose surveillanceEmily Hurstak, Christopher Rowe, Caitlin Turner, et al.
International Journal of STD & AIDS|March 23, 2016
Correlates of recent HIV testing among substance-using men who have sex with menChristopher Rowe, Tim Matheson, Moupali Das, et al.
Neurology|October 10, 2023
Using <sup>18</sup>F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson DiseaseLeah C Beauchamp, Vincent Dore, Victor L Villemagne, et al.
JMIR Public Health and Surveillance|April 27, 2021
The Psychosocial Predictors and Day-Level Correlates of Substance Use Among Participants Recruited via an Online Crowdsourcing Platform in the United States: Daily Diary StudyJennifer Payaal Jain, Claudine Offer, Christopher Rowe, et al.
Frontiers in Neuroscience|January 3, 2022
Generative Model of Brain Microbleeds for MRI Detection of Vascular Marker of Neurodegenerative DiseasesSaba Momeni, Amir Fazlollahi, Leo Lebrat, et al.
Stroke|November 19, 2015
Positron Emission Tomographic Imaging in Stroke: Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic StrokeRamesh Sahathevan, Thomas Linden, Victor L Villemagne, et al.
Internal Medicine Journal|June 22, 2021
Optimising participation of persons with cognitive impairment in a national dementia registry: challenges and solutionsXiaoping Lin, Kasey Wallis, Susannah Ahern, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET studyAlex Bahar-Fuchs, Gael Chételat, Victor L Villemagne, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Annals of Internal Medicine|July 2, 2016
Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for PainPhillip O Coffin, Emily Behar, Christopher Rowe, et al.
Journal of General Internal Medicine|November 6, 2016
Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for PainEmily Behar, Christopher Rowe, Glenn-Milo Santos, et al.
The International Journal on Drug Policy|January 22, 2018
Using medical examiner case narratives to improve opioid overdose surveillanceEmily Hurstak, Christopher Rowe, Caitlin Turner, et al.
International Journal of STD & AIDS|March 23, 2016
Correlates of recent HIV testing among substance-using men who have sex with menChristopher Rowe, Tim Matheson, Moupali Das, et al.
Neurology|October 10, 2023
Using <sup>18</sup>F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson DiseaseLeah C Beauchamp, Vincent Dore, Victor L Villemagne, et al.
JMIR Public Health and Surveillance|April 27, 2021
The Psychosocial Predictors and Day-Level Correlates of Substance Use Among Participants Recruited via an Online Crowdsourcing Platform in the United States: Daily Diary StudyJennifer Payaal Jain, Claudine Offer, Christopher Rowe, et al.
Frontiers in Neuroscience|January 3, 2022
Generative Model of Brain Microbleeds for MRI Detection of Vascular Marker of Neurodegenerative DiseasesSaba Momeni, Amir Fazlollahi, Leo Lebrat, et al.
Stroke|November 19, 2015
Positron Emission Tomographic Imaging in Stroke: Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic StrokeRamesh Sahathevan, Thomas Linden, Victor L Villemagne, et al.
Internal Medicine Journal|June 22, 2021
Optimising participation of persons with cognitive impairment in a national dementia registry: challenges and solutionsXiaoping Lin, Kasey Wallis, Susannah Ahern, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET studyAlex Bahar-Fuchs, Gael Chételat, Victor L Villemagne, et al.
Pageof 10